Clinical Trial Update: Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone [Phase 2]

View source ↗

Summary

Phase 2 study evaluating fluciclovine F-18 PET/CT imaging to assess bone metastases in hormone-naive men with prostate cancer; the trial has completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostate Cancer with Bone Metastases

Drugs mentioned

• Axumin (fluciclovine F-18) (fluciclovine F-18)

Snippet

Sponsor: University of Utah | Conditions: Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone | Phase 2 | Status: COMPLETED | Results posted: 2024-11-29